+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Intracranial Stents Total Addressable Market Research Report by Type, Application, End User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 248 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5715797
UP TO OFF until Mar 31st 2023
The Global Intracranial Stents Total Addressable Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Intracranial Stents Total Addressable Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Intracranial Stents Total Addressable Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Intracranial Stents Total Addressable Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Intracranial Stents Total Addressable Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Intracranial Stents Total Addressable Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Intracranial Stents Total Addressable Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Balloon Expanding Stents, Self-Expanding Stents, and Stent-Assisted Coil Embolization.
  • Based on Application, the market is studied across Brain Aneurysm and Intracranial Stenosis.
  • Based on End User, the market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Intracranial Stents Total Addressable Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Intracranial Stents Total Addressable Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Intracranial Stents Total Addressable Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Intracranial Stents Total Addressable Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Intracranial Stents Total Addressable Market, including Abbott Laboratories, Acandis GmbH, Johnson & Johnson Services, Inc., Medtronic PLC, MicroPort Scientific Corporation, optimed Medizinische Instrumente GmbH, Sino Medical Sciences Technology Inc., Stryker Corporation, and Terumo Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Intracranial Stents Total Addressable Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Intracranial Stents Total Addressable Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Intracranial Stents Total Addressable Market?
4. What is the competitive strategic window for opportunities in the Global Intracranial Stents Total Addressable Market?
5. What are the technology trends and regulatory frameworks in the Global Intracranial Stents Total Addressable Market?
6. What is the market share of the leading vendors in the Global Intracranial Stents Total Addressable Market?
7. What modes and strategic moves are considered suitable for entering the Global Intracranial Stents Total Addressable Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of intracranial disease across the globe
5.1.1.2. Rising preference for minimally invasive intracranial surgeries
5.1.1.3. Increase in number of diagnostic rates
5.1.2. Restraints
5.1.2.1. Associated adverse effects of intracranial stents surgeries
5.1.3. Opportunities
5.1.3.1. Emerging clinical trials and studies by research organizations
5.1.3.2. Ongoing product development and enhancement
5.1.4. Challenges
5.1.4.1. Lack of qualified and skilled professionals
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Intracranial Stents Total Addressable Market, by Type
6.1. Introduction
6.2. Balloon Expanding Stents
6.3. Self-Expanding Stents
6.4. Stent-Assisted Coil Embolization

7. Intracranial Stents Total Addressable Market, by Application
7.1. Introduction
7.2. Brain Aneurysm
7.3. Intracranial Stenosis

8. Intracranial Stents Total Addressable Market, by End User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals

9. Americas Intracranial Stents Total Addressable Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Intracranial Stents Total Addressable Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Intracranial Stents Total Addressable Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Acandis GmbH
13.3. Johnson & Johnson Services, Inc.
13.4. Medtronic PLC
13.5. MicroPort Scientific Corporation
13.6. optimed Medizinische Instrumente GmbH
13.7. Sino Medical Sciences Technology Inc.
13.8. Stryker Corporation
13.9. Terumo Corporation

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET DYNAMICS
FIGURE 11. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 19. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 21. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 24. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 26. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 28. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 30. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 32. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 38. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 39. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 40. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 42. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 43. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 44. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 60. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 82. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 83. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BALLOON EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STENT-ASSISTED COIL EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY INTRACRANIAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. MEXICO INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 66. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. INDIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. JAPAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SINGAPORE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. SOUTH KOREA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. THAILAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. DENMARK INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. EGYPT INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FINLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. FRANCE INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. GERMANY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. ISRAEL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. ITALY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. NIGERIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. NORWAY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 155. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. POLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. QATAR INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SPAIN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. SWITZERLAND INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 187. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. TURKEY INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 199. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 200. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 201. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET RANKING, BY KEY PLAYER, 2022
TABLE 202. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 203. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 204. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET MERGER & ACQUISITION
TABLE 205. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 206. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 207. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET INVESTMENT & FUNDING
TABLE 208. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 209. GLOBAL INTRACRANIAL STENTS TOTAL ADDRESSABLE MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • optimed Medizinische Instrumente GmbH
  • Sino Medical Sciences Technology Inc.
  • Stryker Corporation
  • Terumo Corporation

Methodology

Loading
LOADING...